UCB Chooses Emerson Automation and Operations Management Technologies for One of Europe’s Largest Biotech Plants

  UCB Chooses Emerson Automation and Operations Management Technologies for
  One of Europe’s Largest Biotech Plants

$6.1 million contract includes Syncade™ and DeltaV™ systems to manage complex
             operations while driving toward paperless production

Business Wire

AUSTIN, Texas -- January 9, 2013

Belgium-based UCB has awarded Emerson Process Management, a global business of
Emerson (NYSE: EMR), a $6.1 million contract to provide integrated process
automation and operations management systems for a new biopharmaceutical
production center in Bulle, Switzerland. Emerson’s technologies and
engineering services will be crucial in meeting the very high standards
expected by the UCB project team.

UCB is investing $228 million to construct the first phase of a new plant, its
first biopharmaceutical project in Switzerland. The 20,000-square-meter
facility, which will be one of the largest in Europe, will be the main
production center for Cimzia® (certolizumab pegol), which is used to treat
rheumatoid arthritis and Crohn’s disease.

“The state-of-the-art and largely automated facility at Bulle will be a model
for the industry when it opens in 2015,” said Michele Antonelli, UCB executive
vice president. “To ensure the project meets its tight build-out schedule, we
selected Emerson Process Management for its demonstrated ability to engineer
and coordinate fast-track automation projects of this type.”

Emerson’s integrated solution includes its Syncade™ Smart Operations
Management Suite, DeltaV™ digital automation system, and AMS Suite predictive
maintenance software. Emerson will also provide related engineering services,
including design, installation, testing, and commissioning.

The Syncade Suite software integrates real-time plant floor data with business
processes, decisions, and asset management – a key advantage in managing
complex operations and extensive documentation required in pharmaceutical
production. Syncade Suite manages workflow processes, including electronic
work instructions, equipment status and material tracking, recipe-driven
operations, automated weigh and dispense operations, and exception reporting.

“Typical biotech manufacturing can involve thousands of pieces of paper that
can affect the ability to produce ‘right-first-time’ batches,” said Lorenzo
Zampini, automation project manager. “With Emerson’s integrated operations
management and control systems, we can automate the reporting process as well
as gain tighter process control for increased productivity and smoother
regulatory compliance.”

The Syncade software integrates with Emerson’s DeltaV automation system to
facilitate operational activities and information flow from the plant floor up
to UCB’s SAP system. In the UCB plant, the DeltaV system will control 163
process units including fermentation, purification, filtration, and bottling.
Emerson’s new electronic marshalling technology with CHARMs (characterization
modules) will help minimize installation time by eliminating up to two-thirds
of the wiring and connections needed with traditional control systems.

Emerson’s AMS Suite predictive maintenance software that will be supporting
HART instrumentation will make it easy for technicians to calibrate critical
instruments, check their status, and even detects potential problems before
they affect operations.

“Emerson is delighted that UCB has chosen us to automate this ground-breaking
facility,” said Steve Sonnenberg, president of Emerson Process Management.
“Our proven ability to provide a single source for both plant automation and
operations management systems will help UCB seamlessly manage operations from
the plant floor to the head office. We look forward to working with them as
they bring the Bulle facility to life.”

About Emerson Process Management

Emerson Process Management (www.emersonprocess.com), an Emerson business, is a
leader in helping businesses automate their production, processing, and
distribution in the chemical, oil and gas, refining, pulp and paper, power,
water and wastewater treatment, mining and metals, food and beverage, life
sciences, and other industries. The company combines superior products and
technology with industry-specific engineering, consulting, project management,
and maintenance services. Its brands include PlantWeb™, Syncade™, DeltaV™,
Fisher®, Micro Motion®, Rosemount®, Daniel™, Ovation™, and AMS Suite.

About Emerson

Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global leader in
bringing technology and engineering together to provide innovative solutions
for customers in industrial, commercial, and consumer markets around the
world. The company is comprised of five business segments: Process Management,
Industrial Automation, Network Power, Climate Technologies, and Commercial &
Residential Solutions. Sales in fiscal 2012 were $24.4 billion. For more
information, visit www.Emerson.com.

Contact:

For Emerson
Denise Clarke, 512-899-0004
denise.clarke@fleishman.com